MHC2Pred

MHC2Pred predicts promiscuous peptide binding to MHC class II alleles using support vector machine (SVM) models to identify peptides that bind across 42 MHC class II alleles for immunoinformatics applications such as vaccine design and immunotherapy.

Key Features:

• Machine Learning Approach: Uses support vector machine (SVM) models trained to predict peptide binding across 42 MHC class II alleles.
• Promiscuous Binding Prediction: Identifies peptides capable of binding multiple MHC class II alleles rather than focusing on single allele–peptide interactions.
• Validation and Accuracy: Performance was evaluated using 5-fold cross-validation, yielding an average accuracy of approximately 80% across the 42 alleles.
• Dataset Limitations: Predictive performance is reduced for certain alleles that have smaller training dataset sizes.

Scientific Applications:

• Vaccine Development: Identification of broadly binding peptides to inform design of vaccines that target multiple MHC class II alleles.
• Immunotherapy: Selection of candidate peptides and neoantigens likely to be presented across diverse patient populations for cancer immunotherapy.
• Basic Immunology Research: Investigation of promiscuous binding patterns to advance understanding of antigen presentation and CD4+ T-cell activation.

Methodology:

Support vector machines trained on known peptide–MHC class II interactions with performance assessed by 5-fold cross-validation.